Zobrazeno 31 - 40
of 393
pro vyhledávání: '"Jürgen K. Rockstroh"'
Autor:
Christoph Boesecke, Jenny Bischoff, Jürgen K. Rockstroh, Stefan Christensen, Axel Baumgarten, Patrick Ingiliz, Florian Berger, Thomas A. Lutz, Stefan Mauss, Julian Schulze zur Wiesch, Karl-Georg Simon, Carl Knud Schewe, Dietrich Hueppe
Publikováno v:
Journal of Clinical Gastroenterology. 54:192-199
International guidelines recommend prioritized treatment initiation in hepatitis C virus (HCV)-infected patients with advanced liver disease. We aimed to evaluate whether the widespread usage of direct acting antivirals (DAAs) has led to a decrease i
Publikováno v:
CME. 16:9-19
Autor:
Gereon J Rieke, Kathrin van Bremen, Jenny Bischoff, Michael ToVinh, Malte B Monin, Stefan Schlabe, Jan Raabe, Kim M Kaiser, Claudia Finnemann, Alexandru Odainic, Anushka Kudaliyanage, Eicke Latz, Christian P Strassburg, Christoph Boesecke, Susanne V Schmidt, Benjamin Krämer, Jürgen K Rockstroh, Jacob Nattermann
Publikováno v:
The Journal of infectious diseases. 225(10)
We compared the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-specific antibodies to induce natural killer cell-mediated antibody-dependent cellular cytotoxicity (ADCC) in patients with natural infection and vaccinated
Autor:
Kamal Mansinho, Georg M. N. Behrens, Santiago Moreno, Olga Fursa, Line D Rasmussen, Amanda Mocroft, Sarah Amele, Raimonda Matulionyte, Jose Joaquin Portu, Anna Vassilenko, Gilles Wandeler, Jürgen K. Rockstroh, Lars Peters, David Jilich, Johanna Brännström, Karine Lacombe, Lothar Wiese, Elena Borodulina, Jeffrey V. Lazarus, Chloe Orkin, EuroSIDA study, Jens D Lundgren, Miłosz Parczewski
Publikováno v:
Fursa, O, Mocroft, A, Lazarus, J V, Amele, S, Lundgren, J, Matulionyte, R, Rasmussen, L D, Rockstroh, J K, Parczewski, M, Jilich, D, Moreno, S, Vassilenko, A, Lacombe, K, Wandeler, G, Borodulina, E, Brännström, J, Wiese, L, Orkin, C, Behrens, G M N, Mansinho, K, Portu, J J, Peters, L & EuroSIDA Study 2022, ' The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe : Regional and intra-regional differences ', AIDS (London, England), vol. 36, no. 3, pp. 423-435 . https://doi.org/10.1097/QAD.0000000000003112
Background: Following the introduction of direct-acting antiviral therapy in 2013, WHOlaunched the first Global Health Sector Strategy on Viral Hepatitis. We describe a hepatitis C virus (HCV) cascade of care in people with HIV (PWH) across Europe in
Autor:
Malte B, Monin, Benjamin, Marx, Lisa, Meffert, Christoph, Boesecke, Jürgen K, Rockstroh, Christian P, Strassburg, Peter, Brossart, Annkristin, Heine
Publikováno v:
Annals of Hematology. 101:2089-2090
Autor:
Jenny, Bischoff, Stefan, Mauss, Thomas, Lutz, Christiane, Cordes, Gerd, Klausen, Stefan, Scholten, Heribert, Hillenbrand, Markus, Cornberg, Axel, Baumgarten, Jürgen K, Rockstroh, Stefan, Zeuzem
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(11)
Publikováno v:
Journal of Antimicrobial Chemotherapy
Autor:
Eliav Barr, Barbara Haber, Michael N. Robertson, Frederick L. Altice, Lawrence Serfaty, Ira M. Jacobson, Peggy Hwang, Jürgen K. Rockstroh
Publikováno v:
Journal of Viral Hepatitis. 26:329-336
European treatment guidelines for hepatitis C virus (HCV) infection recommend that people with genotype (GT) 1a infection and baseline viral load ≤800 000 IU/mL receive elbasvir/grazoprevir (EBR/GZR) for 12 weeks, and those with baseline viral load
Autor:
David L. Wyles, Yves Horsmans, Erica Villa, Sarah Kopecky-Bromberg, Tania M. Welzel, Armen Asatryan, Preethi Krishnan, Federico J. Mensa, Stephen D. Ryder, Roger Trinh, Ola Weiland, David Mutimer, Peter Ruane, Stanley Wang, Edward Gane, Teresa I. Ng, Jürgen K. Rockstroh, Sandra S. Lovell, Zhenyi Xue, Jeong Heo, Kosh Agarwal, Paul Y. Kwo, Steven L. Flamm
Publikováno v:
Journal of Viral Hepatitis
Journal of viral hepatitis, Vol. 26, no. 3, p. 337-349 (2019)
Journal of viral hepatitis, Vol. 26, no. 3, p. 337-349 (2019)
Summary Glecaprevir coformulated with pibrentasvir (G/P) is approved to treat hepatitis C virus (HCV) infection and was highly efficacious in phase 2 and 3 studies. Treating HCV genotype (GT) 3 infection remains a priority, as these patients are hard
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 143:1755-1758
Was ist neu? Zerebrale Toxoplasmose Als intravenöse Therapie ist die Gabe von Trimethoprim und Sulfamethoxazol möglich. Auch als orale Prophylaxe können sie nun schon ab einer CD4-T-Helferzellzahl von Pneumocystis jiroveci Zur Prophylaxe und Thera